When LUCENTIS was administered 7 days (±2 days) after PDT, serious intraocular inflammation developed in 11% of neovascular AMD patients (10 of 12 cases). Timing of administration appears critical.
Source: NLP:ranibizumab
Steroid Therapy Interactions
9 interactions on record
Serious intraocular inflammation occurred in 11% of patients when ranibizumab was administered 7 days (± 2 days) after PDT. In 10 of 12 cases, inflammation occurred at this timing interval.
Source: NLP:ranibizumab-eqrn
Steroid Therapy + DoxycyclineModerate
Tetracyclines depress plasma prothrombin activity; patients may require downward adjustment of anticoagulant dosage.
Source: NLP:doxycycline
Tetracyclines depress plasma prothrombin activity; patients may require downward adjustment of anticoagulant dosage.
Source: NLP:doxycycline hyclate
ADT can result in changes in uptake of gallium Ga 68 gozetotide in prostate cancer. Effect on PET performance has not been established.
Source: NLP:kit for the preparation of gallium ga 68 gozetotide injection
Steroid Therapy + MethazolamideModerate
Potential for developing hypokalemia when used concomitantly with methazolamide; caution advised.
Source: NLP:methazolamide
Tetracyclines depress plasma prothrombin activity; patients may require downward adjustment of anticoagulant dosage.
Source: NLP:minocycline hydrochloride
Steroid Therapy + SomatropinModerate
May require initiation of glucocorticoid replacement therapy or increase in maintenance doses due to somatropin inhibition of 11βHSD-1 and reduced serum cortisol concentrations.
Source: NLP:somatropin
Tetracycline depresses plasma prothrombin activity, requiring possible downward adjustment of anticoagulant dosage.
Source: NLP:tetracycline hydrochloride